Literature DB >> 20837111

Identifying botanical mechanisms of action.

May Fern Toh1, Joanna E Burdette.   

Abstract

The biological mechanism of action for any botanical extract is a necessary part of discovery to determine pharmacological use and safety. Interestingly, many activities that are governed by endogenous compounds are not fully understood making the characterization of mechanisms elusive. For example, phytoestrogens are being consumed for menopausal symptoms while the biological action of estradiol are still being investigated. Therefore, long term efficacy and safety issues are a challenge in the field. As new activities are associated with new biological pathways, an important component of therapeutic discovery will need to be the re-evaluation of negative or less active natural products to determine their relative use as medicines.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837111      PMCID: PMC3026059          DOI: 10.1016/j.fitote.2010.09.003

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  45 in total

Review 1.  Treatment of menopausal symptoms.

Authors:  Iris L Tong
Journal:  Compr Ther       Date:  2008

2.  Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats.

Authors:  Joanna E Burdette; Jianghua Liu; Dan Lantvit; Eula Lim; Nancy Booth; Krishna P L Bhat; Samad Hedayat; Richard B Van Breemen; Andreas I Constantinou; John M Pezzuto; Norman R Farnsworth; Judy L Bolton
Journal:  J Nutr       Date:  2002-01       Impact factor: 4.798

3.  Effects of botanicals and combined hormone therapy on cognition in postmenopausal women.

Authors:  Pauline M Maki; Leah H Rubin; Deanne Fornelli; Lauren Drogos; Suzanne Banuvar; Lee P Shulman; Stacie E Geller
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

Review 4.  Estrogen receptor knockout mice: phenotypes in the female reproductive tract.

Authors:  J M A Emmen; K S Korach
Journal:  Gynecol Endocrinol       Date:  2003-04       Impact factor: 2.260

5.  Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial.

Authors:  Stacie E Geller; Lee P Shulman; Richard B van Breemen; Suzanne Banuvar; Ying Zhou; Geena Epstein; Samad Hedayat; Dejan Nikolic; Elizabeth C Krause; Colleen E Piersen; Judy L Bolton; Guido F Pauli; Norman R Farnsworth
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

6.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

Review 7.  The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.

Authors:  Helena M Verkooijen; Christine Bouchardy; Vincent Vinh-Hung; Elisabetta Rapiti; Mikael Hartman
Journal:  Maturitas       Date:  2009-08-25       Impact factor: 4.342

8.  Characterization of the ovarian and reproductive abnormalities in prepubertal and adult estrogen non-responsive estrogen receptor alpha knock-in (ENERKI) mice.

Authors:  K W Sinkevicius; K Woloszyn; M Laine; K S Jackson; G L Greene; T K Woodruff; J E Burdette
Journal:  Steroids       Date:  2009-07-23       Impact factor: 2.668

9.  Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.

Authors:  C M Weaver; B R Martin; G S Jackson; G P McCabe; J R Nolan; L D McCabe; S Barnes; S Reinwald; M E Boris; M Peacock
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

10.  In vivo imaging of transcriptionally active estrogen receptors.

Authors:  Paolo Ciana; Michele Raviscioni; Paola Mussi; Elisabetta Vegeto; Ivo Que; Malcolm G Parker; Clemens Lowik; Adriana Maggi
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.